Small molecule SMU-CX24 targeting toll-like receptor 3 counteracts inflammation: A novel approach to atherosclerosis therapy
Xiaohong Cen(Guangdong Pharmaceutical University), Kui Cheng(Southern Medical University), Yu Xiao(Southern Medical University), Baoqu Wang(Kunming University of Science and Technology), Shuwen Liu(Zhengzhou University), Yanlin Chen(Nanjing University of Chinese Medicine), Yuqing Liang(Shanghai Jiao Tong University), Hang Yin(Cornell University), Shaohua Du(Third Affiliated Hospital of Southern Medical University), Kutty Selva Nandakumar(Southern Medical University)
Cited by 28
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Evidence that opioids may have toll-like receptor 4 and MD-2 effects
|Brain Behavior and Immunity|2009|574
Morphine activates neuroinflammation in a manner parallel to endotoxin
|Proceedings of the National Academy of Sciences|2012|512
Strategies for Targeting Protein–Protein Interactions With Synthetic Agents
|Angewandte Chemie International Edition|2005|449